Personal Information
Organization / Workplace
New York, NY United States
Occupation
Chairman and Chief Executive Officer
Industry
Finance / Banking / Insurance
Website
lindsayrosenwald.com/
About
Throughout his career, Dr. Lindsay Rosenwald has championed numerous biotechnology entrepreneurs and researchers. Currently a co-founder and partner of an asset management firm, the industry veteran has a track record of success in bringing medical treatment development projects to fruition. He has played an integral role in securing approval from federal and international authorities for more than one dozen devices and medications. Leveraging two decades of experience in the biotech sector, Dr. Lindsay Rosenwald continues to identify up-and-coming companies as the industry increasingly expands.
Tags
lindsay rosenwald
zytiga
research
drug discovery
pharmaceutical
health
dr. lindsay rosenwald
biotechnology
cancer
medicine
pharmaceuticals
opus point partners
lung cancer
protein
esophageal cancer
genetic contributors
blood test could aid in early breast cancer diagno
men
benefits
prostate cancer patients
biotechnology company
acquisition
johnson & johnson
pets
veterinary medicine
21st century
target identification
validation
fda approval
prostate cancer treatment
active surveillance
prostate cancer
chemotherapy
treatment
overactive bladder
behavioral treatments
immune system
women greater risk
biotech
joint falls out of alignment
investment partnership
family history of rheumatoid arthritis
risk factors of rheumatoid arthritis
joint membranes
some information on acute promyelocytic leukemia
cancer treatment drug
amgen
recognition
cancer work
temple director
prostate cancer treatment drug may have wider uses
the board of visitors at temple university's schoo
cancer research
combination therapy
pharmaceutical drug
cancer-fighting
abiraterone acetate
cougar biotechnology
cancer diagnosis
cancer staging
oncology
biopharmaceuticals
disease
schizophrenia
li
temple university school of medicine board of visi
milnacipran
fibromyalgia
influenza
dr. lindsay a. rosenwald
new drug development
clinical trials
See more
Presentations
(12)Personal Information
Organization / Workplace
New York, NY United States
Occupation
Chairman and Chief Executive Officer
Industry
Finance / Banking / Insurance
Website
lindsayrosenwald.com/
About
Throughout his career, Dr. Lindsay Rosenwald has championed numerous biotechnology entrepreneurs and researchers. Currently a co-founder and partner of an asset management firm, the industry veteran has a track record of success in bringing medical treatment development projects to fruition. He has played an integral role in securing approval from federal and international authorities for more than one dozen devices and medications. Leveraging two decades of experience in the biotech sector, Dr. Lindsay Rosenwald continues to identify up-and-coming companies as the industry increasingly expands.
Tags
lindsay rosenwald
zytiga
research
drug discovery
pharmaceutical
health
dr. lindsay rosenwald
biotechnology
cancer
medicine
pharmaceuticals
opus point partners
lung cancer
protein
esophageal cancer
genetic contributors
blood test could aid in early breast cancer diagno
men
benefits
prostate cancer patients
biotechnology company
acquisition
johnson & johnson
pets
veterinary medicine
21st century
target identification
validation
fda approval
prostate cancer treatment
active surveillance
prostate cancer
chemotherapy
treatment
overactive bladder
behavioral treatments
immune system
women greater risk
biotech
joint falls out of alignment
investment partnership
family history of rheumatoid arthritis
risk factors of rheumatoid arthritis
joint membranes
some information on acute promyelocytic leukemia
cancer treatment drug
amgen
recognition
cancer work
temple director
prostate cancer treatment drug may have wider uses
the board of visitors at temple university's schoo
cancer research
combination therapy
pharmaceutical drug
cancer-fighting
abiraterone acetate
cougar biotechnology
cancer diagnosis
cancer staging
oncology
biopharmaceuticals
disease
schizophrenia
li
temple university school of medicine board of visi
milnacipran
fibromyalgia
influenza
dr. lindsay a. rosenwald
new drug development
clinical trials
See more